Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report

Ketamine as a new treatment for depression: A review of its efficacy and adverse effects

(2013) Natalie Katalinic et al.   AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY

Ketamine as a Fast Acting Antidepressant: Current Knowledge and Open Questions

(2013) Giacomo Salvadore et al.   CNS Neuroscience & Therapeutics

Health status of ayahuasca users

(2012) Paulo Cesar Ribeiro Barbosa et al.   Drug Testing and Analysis

Mental Disorders in Megacities: Findings from the São Paulo Megacity Mental Health Survey, Brazil

(2012) Laura Helena Andrade et al.   PLoS One

Personality, Psychopathology, Life Attitudes and Neuropsychological Performance among Ritual Users of Ayahuasca: A Longitudinal Study

(2012) José Carlos Bouso et al.   PLoS One

Autonomic, Neuroendocrine, and Immunological Effects of Ayahuasca

(2011) Rafael G. dos Santos et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Harmine and Imipramine Promote Antioxidant Activities in Prefrontal Cortex and Hippocampus

(2011) Gislaine Z. Réus et al.   Oxidative Medicine and Cellular Longevity

Pharmacology of ayahuasca administered in two repeated doses

(2011) Rafael G. dos Santos et al.   PSYCHOPHARMACOLOGY

Chronic administration of harmine elicits antidepressant-like effects and increases BDNF levels in rat hippocampus

(2010) Jucélia J. Fortunato et al.   JOURNAL OF NEURAL TRANSMISSION

Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model

(2009) Chao Wu et al.   BIOCHEMICAL PHARMACOLOGY

Effects of β-carboline harmine on behavioral and physiological parameters observed in the chronic mild stress model: Further evidence of antidepressant properties

(2009) Jucélia J. Fortunato et al.   BRAIN RESEARCH BULLETIN

Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus

(2009) Jucélia J. Fortunato et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Human hallucinogen research: guidelines for safety

(2008) MW Johnson et al.   JOURNAL OF PSYCHOPHARMACOLOGY